文献速递脑血管病外科神经重症

未破裂脑动静脉畸形手术与保守治疗12个月后的生活质量和残疾:苏格兰人群研究和澳大利亚医院研究

Quality of life and disability 12 months after surgery vs. conservative management for unruptured brain arteriovenous malformations: Scottish population-based and Australian hospital-based studies.
PubMed 文献 · Acta Neurochir (Wien) · 2018-01-11

本研究基于苏格兰前瞻性人群研究(1999-2003;2006-2010)和澳大利亚前瞻性医院系列(2011-2015),比较未破裂脑动静脉畸形手术(±术前栓塞)与保守治疗约12个月后的生活质量和残疾。苏格兰79例和澳大利亚37例中,两组在SF-36生理成分评分、心理成分评分及mRS>1比例上均无统计学显著差异。澳大利亚系列中,基线至12个月的心理和生理成分评分无统计学显著变化。

要点

  • 苏格兰队列中手术组与保守组12个月SF-36 PCS和MCS及mRS>1比例无统计学显著差异。
  • 澳大利亚队列中手术组与保守组12个月SF-36 PCS和MCS及mRS>1比例无统计学显著差异。
  • 澳大利亚系列中基线至12个月MCS和PCS无统计学显著变化。

核心结论

  • 手术±术前栓塞与保守治疗在12个月时的残疾或生活质量方面无统计学显著差异。

研究设计与样本

  • 研究纳入苏格兰前瞻性人群研究(1999-2003;2006-2010)和澳大利亚前瞻性医院系列(2011-2015)中连续诊断为未破裂脑动静脉畸形的患者。
  • 在手术或保守治疗后约12个月评估改良Rankin量表(mRS)和Short Form(SF)-36,并在两个队列中分别使用连续序数回归进行比较。

主要发现

  • 苏格兰队列79例患者中,手术组与保守组12个月时平均SF-36生理成分评分(PCS)39(SD 14) vs. 39(SD 13),平均心理成分评分(MCS)38(SD 14) vs. 39(SD 14),mRS>1比例24 vs. 9%,均无统计学显著差异。
  • 澳大利亚队列37例患者中,手术组与保守组12个月时PCS 51(SD 10) vs. 49(SD 6),MCS 48(SD 12) vs. 49(SD 10),mRS>1比例19 vs. 30%,均无统计学显著差异。
  • 澳大利亚系列中,手术或保守治疗前基线至12个月之间MCS和PCS无统计学显著变化。
  • 苏格兰所有诊断的未破裂脑动静脉畸形病例中29%接受了手术,澳大利亚所有转诊的未破裂脑动静脉畸形中84%接受了手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few data are available on disability and quality of life (QOL) after surgery versus conservative management for unruptured brain arteriovenous malformations (uAVMs). OBJECTIVE: The aim of this study was to test the hypothesis that QOL and disability are worse after surgery ± preoperative embolisation for uAVM compared with conservative management. METHODS: We included consecutive patients diagnosed with uAVM from a prospective population-based study in Scotland (1999-2003; 2006-2010) and a prospective hospital-based series in Australia (2011-2015). We assessed outcomes on the modified Rankin Scale (mRS) and the Short Form (SF)-36 at ~ 12 months after surgery or conservative treatment and compared these groups using continuous ordinal regression in the two cohorts separately. RESULTS: Surgery was performed for 29% of all uAVM cases diagnosed in Scotland and 84% of all uAVM referred in Australia. There was no statistically significant difference between surgery and conservative management at 12 months among 79 patients in Scotland (mean SF-36 Physical Component Score (PCS) 39 [SD 14] vs. 39 [SD 13]; mean SF-36 Mental Component Score (MCS) 38 [SD 14] vs. 39 [SD 14]; mRS > 1, 24 vs. 9%), nor among 37 patients in Australia (PCS 51 [SD 10] vs. 49 [SD 6]; MCS 48 [SD 12] vs. 49 [SD 10]; mRS > 1, 19 vs. 30%). In the Australian series, there was no statistically significant change in the MCS and PCS between baseline before surgery or conservative management and 12 months. CONCLUSIONS: We did not find a statistically significant difference between surgery ± preoperative embolisation and conservative management in disability or QOL at 12 months.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. O'Donnell JM, Al-Shahi Salman R, Manuguerra M, et al. Quality of life and disability 12 months after surgery vs. conservative management for unruptured brain arteriovenous malformations: Scottish population-based and Australian hospital-based studies. Acta Neurochir (Wien). 2018. PMID: 29327142. doi:10.1007/s00701-017-3451-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。